Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Poolbeg Pharma Ltd. ( (GB:POLB) ) has shared an announcement.
Poolbeg Pharma PLC, a pharmaceutical company, has received a notification regarding a change in major holdings. Allan Rankin has acquired a 3.24% voting rights position in the company as of January 7, 2025. This acquisition signifies a noteworthy shift in the company’s shareholder structure, potentially impacting future voting outcomes and strategic decisions.
More about Poolbeg Pharma Ltd.
YTD Price Performance: -36.62%
Average Trading Volume: 1,995,394
Technical Sentiment Consensus Rating: Buy
For a thorough assessment of POLB stock, go to TipRanks’ Stock Analysis page.